Trade Alibaba Health Information Technology Limited - 0241 CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.06 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026116% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.004199% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | HKD | ||||||||
Margin | 5% | ||||||||
Stock exchange | Hong Kong | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Alibaba Health Information Technology Ltd ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 4.35 |
Open* | 4.35 |
1-Year Change* | -40.41% |
Day's Range* | 4.29 - 4.46 |
52 wk Range | 4.25-10.14 |
Average Volume (10 days) | 26.91M |
Average Volume (3 months) | 565.03M |
Market Cap | 62.66B |
P/E Ratio | 107.66 |
Shares Outstanding | 13.53B |
Revenue | 29.24B |
EPS | 0.04 |
Dividend (Yield %) | N/A |
Beta | 1.95 |
Next Earnings Date | N/A |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 4, 2023 | 4.35 | -0.03 | -0.68% | 4.38 | 4.49 | 4.31 |
Dec 1, 2023 | 4.35 | -0.08 | -1.81% | 4.43 | 4.44 | 4.32 |
Nov 30, 2023 | 4.42 | -0.24 | -5.15% | 4.66 | 4.66 | 4.37 |
Nov 29, 2023 | 4.59 | -0.31 | -6.33% | 4.90 | 4.92 | 4.53 |
Nov 28, 2023 | 4.63 | 0.00 | 0.00% | 4.63 | 4.66 | 4.55 |
Nov 27, 2023 | 4.63 | 0.06 | 1.31% | 4.57 | 4.69 | 4.55 |
Nov 24, 2023 | 4.55 | -0.10 | -2.15% | 4.65 | 4.65 | 4.54 |
Nov 23, 2023 | 4.66 | 0.08 | 1.75% | 4.58 | 4.67 | 4.56 |
Nov 22, 2023 | 4.61 | -0.05 | -1.07% | 4.66 | 4.67 | 4.57 |
Nov 21, 2023 | 4.62 | -0.09 | -1.91% | 4.71 | 4.83 | 4.61 |
Nov 20, 2023 | 4.66 | 0.15 | 3.33% | 4.51 | 4.69 | 4.51 |
Nov 17, 2023 | 4.57 | -0.16 | -3.38% | 4.73 | 4.76 | 4.43 |
Nov 16, 2023 | 4.87 | -0.07 | -1.42% | 4.94 | 4.95 | 4.81 |
Nov 15, 2023 | 4.94 | 0.00 | 0.00% | 4.94 | 4.98 | 4.87 |
Nov 14, 2023 | 4.79 | 0.01 | 0.21% | 4.78 | 4.83 | 4.76 |
Nov 13, 2023 | 4.80 | 0.09 | 1.91% | 4.71 | 4.81 | 4.66 |
Nov 10, 2023 | 4.69 | -0.01 | -0.21% | 4.70 | 4.73 | 4.65 |
Nov 9, 2023 | 4.76 | -0.10 | -2.06% | 4.86 | 4.94 | 4.74 |
Nov 8, 2023 | 4.89 | 0.04 | 0.82% | 4.85 | 5.02 | 4.82 |
Nov 7, 2023 | 4.84 | -0.04 | -0.82% | 4.88 | 5.01 | 4.84 |
Alibaba Health Information Technology Limited Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Total revenue | 26763 | 20577.6 | 15518.5 | 9596.48 | 5095.87 |
Revenue | 26763 | 20577.6 | 15518.5 | 9596.48 | 5095.87 |
Cost of Revenue, Total | 21061.7 | 16469.6 | 11901.2 | 7365.1 | 3764.6 |
Gross Profit | 5701.33 | 4107.99 | 3617.25 | 2231.38 | 1331.26 |
Total Operating Expense | 26217.6 | 20780.7 | 15076.4 | 9531.38 | 5127.09 |
Selling/General/Admin. Expenses, Total | 2161.5 | 2376.49 | 1529.68 | 947.106 | 638.17 |
Research & Development | 677.822 | 728.828 | 423.632 | 252.843 | 219.018 |
Interest Expense (Income) - Net Operating | -454.218 | -415.342 | -309.776 | -29.33 | -51.304 |
Unusual Expense (Income) | -60.21 | -380.177 | -82.196 | -63.584 | -12.432 |
Other Operating Expenses, Total | 2830.99 | 2001.27 | 1613.83 | 1059.25 | 569.031 |
Operating Income | 545.446 | -203.079 | 442.081 | 65.091 | -31.22 |
Interest Income (Expense), Net Non-Operating | 5.548 | -49.435 | -40.862 | -55.997 | -29.61 |
Net Income Before Taxes | 550.994 | -252.514 | 401.219 | 9.094 | -60.83 |
Net Income After Taxes | 534.263 | -265.941 | 342.68 | -15.696 | -91.764 |
Minority Interest | -0.856 | 0.386 | 5.908 | 9.11 | 9.815 |
Net Income Before Extra. Items | 533.407 | -265.555 | 348.588 | -6.586 | -81.949 |
Net Income | 533.407 | -265.555 | 348.588 | -6.586 | -81.949 |
Income Available to Common Excl. Extra. Items | 533.407 | -265.555 | 348.588 | -6.586 | -81.949 |
Income Available to Common Incl. Extra. Items | 533.407 | -265.555 | 348.588 | -6.586 | -81.949 |
Diluted Net Income | 533.407 | -265.555 | 348.588 | -6.586 | -81.949 |
Diluted Weighted Average Shares | 13541.6 | 13482.6 | 13326.5 | 11931.3 | 11055 |
Diluted EPS Excluding Extraordinary Items | 0.03939 | -0.0197 | 0.02616 | -0.00055 | -0.00741 |
Diluted Normalized EPS | 0.03508 | -0.03802 | 0.02095 | -0.00402 | -0.00814 |
Mar 2023 | Sep 2022 | Mar 2022 | Sep 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total revenue | 15262.4 | 11500.6 | 11219.9 | 9357.71 | 8356.44 |
Revenue | 15262.4 | 11500.6 | 11219.9 | 9357.71 | 8356.44 |
Cost of Revenue, Total | 11861.8 | 9199.91 | 8982.68 | 7486.94 | 6599.5 |
Gross Profit | 3400.68 | 2300.66 | 2237.22 | 1870.78 | 1756.93 |
Total Operating Expense | 14894 | 11323.6 | 11218.2 | 9562.46 | 8279.28 |
Selling/General/Admin. Expenses, Total | 1117.37 | 1032.62 | 1221.41 | 1158.93 | 881.62 |
Research & Development | 353.836 | 323.986 | 406.078 | 322.75 | 194.183 |
Interest Expense (Income) - Net Operating | -260.821 | -156.512 | -91.366 | -548.078 | -245.832 |
Unusual Expense (Income) | -62.356 | -1.021 | -357.811 | -23.723 | -73.517 |
Other Operating Expenses, Total | 1884.16 | 924.632 | 1057.25 | 1165.64 | 923.32 |
Operating Income | 368.494 | 176.952 | 1.661 | -204.74 | 77.159 |
Interest Income (Expense), Net Non-Operating | 8.525 | -2.977 | -24.313 | -25.122 | -0.381 |
Net Income Before Taxes | 377.019 | 173.975 | -22.652 | -229.862 | 76.778 |
Net Income After Taxes | 372.287 | 161.976 | -34.373 | -231.568 | 64.126 |
Minority Interest | 0.459 | -1.315 | 0.589 | -0.203 | 1.031 |
Net Income Before Extra. Items | 372.746 | 160.661 | -33.784 | -231.771 | 65.157 |
Net Income | 372.746 | 160.661 | -33.784 | -231.771 | 65.157 |
Income Available to Common Excl. Extra. Items | 372.746 | 160.661 | -33.784 | -231.771 | 65.157 |
Income Available to Common Incl. Extra. Items | 372.746 | 160.661 | -33.784 | -231.771 | 65.157 |
Diluted Net Income | 372.746 | 160.661 | -33.784 | -231.771 | 65.157 |
Diluted Weighted Average Shares | 13562.1 | 13521.1 | 13487.3 | 13477.9 | 13614.8 |
Diluted EPS Excluding Extraordinary Items | 0.02748 | 0.01188 | -0.0025 | -0.0172 | 0.00479 |
Diluted Normalized EPS | 0.02294 | 0.01181 | -0.01975 | -0.01834 | 0.00028 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Total Current Assets | 14913.8 | 13565.5 | 14199.7 | 5013 | 3303.39 |
Cash and Short Term Investments | 10917.2 | 10547.9 | 11636.8 | 2997.47 | 2017.08 |
Cash | 8941.31 | 8325.42 | 6419.69 | 2033.26 | |
Cash & Equivalents | 280.371 | ||||
Short Term Investments | 1975.86 | 2222.43 | 5217.08 | 964.204 | 1736.71 |
Total Receivables, Net | 1279.34 | 1073.94 | 772.908 | 589.166 | 538.798 |
Accounts Receivable - Trade, Net | 578.787 | 515.985 | 313.615 | 324.541 | 365.446 |
Total Inventory | 2102.31 | 1550.15 | 1468.61 | 1217.26 | 595.793 |
Prepaid Expenses | 464.7 | 330.447 | 310.423 | 148.867 | 150 |
Other Current Assets, Total | 150.262 | 63.125 | 11.017 | 60.239 | 1.719 |
Total Assets | 20747.6 | 19202 | 17739.2 | 7869.97 | 5981.88 |
Property/Plant/Equipment, Total - Net | 68.548 | 165.106 | 52.289 | 72.332 | 8.886 |
Property/Plant/Equipment, Total - Gross | 150.854 | 245.073 | 133.548 | 149.506 | 76.836 |
Accumulated Depreciation, Total | -82.306 | -79.967 | -81.259 | -77.174 | -67.95 |
Goodwill, Net | 810.853 | 810.853 | 54.576 | 54.576 | 27.006 |
Long Term Investments | 4591.5 | 4303.86 | 3420.15 | 2703.87 | 2603.23 |
Note Receivable - Long Term | 20.024 | 13.03 | 9.524 | 21.732 | 39.372 |
Other Long Term Assets, Total | 33.831 | 17.39 | |||
Total Current Liabilities | 5437.44 | 4822.13 | 3400.87 | 2609.9 | 3233.38 |
Accounts Payable | 3714.05 | 3528.6 | 2551.55 | 1865.53 | 902.651 |
Accrued Expenses | 176.064 | 169.815 | 105.73 | 59.645 | 56.518 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 1700 |
Other Current Liabilities, Total | 1509.9 | 1073.06 | 723.258 | 652.702 | 574.213 |
Total Liabilities | 5573.85 | 5103.55 | 3437.25 | 2600.83 | 3187.37 |
Total Long Term Debt | 40.361 | 84.758 | 17.406 | 37.725 | 0 |
Long Term Debt | 0 | ||||
Deferred Income Tax | 122.417 | 116.483 | 39.322 | 19.829 | 11.677 |
Minority Interest | -26.374 | -26.187 | -20.346 | -66.63 | -57.693 |
Total Equity | 15173.7 | 14098.4 | 14302 | 5269.15 | 2794.52 |
Common Stock | 119.133 | 119.102 | 118.859 | 106.108 | 102.898 |
Additional Paid-In Capital | 43734.1 | 43499.9 | 43281.3 | 22344.7 | 20044.2 |
Retained Earnings (Accumulated Deficit) | -28706 | -29261.2 | -29031.4 | -17571.6 | -17635.3 |
Treasury Stock - Common | -70.482 | -23.516 | -22.265 | -13.039 | -25.052 |
ESOP Debt Guarantee | 477.237 | 460.077 | 363.949 | 210.73 | 231.955 |
Other Equity, Total | -380.919 | -724.479 | -452.462 | 150.697 | 75.873 |
Total Liabilities & Shareholders’ Equity | 20747.6 | 19202 | 17739.2 | 7869.97 | 5981.88 |
Total Common Shares Outstanding | 13521.4 | 13505.2 | 13475.4 | 12061.6 | 11698.3 |
Intangibles, Net | 309.01 | 326.215 | 2.935 | 4.467 | |
Current Port. of LT Debt/Capital Leases | 37.437 | 50.656 | 20.334 | 32.03 | |
Capital Lease Obligations | 40.361 | 84.758 | 17.406 | 37.725 | |
Unrealized Gain (Loss) | 0.613 | 28.529 | 43.971 | 41.545 | |
Other Liabilities, Total | 0 | 106.363 |
Mar 2023 | Sep 2022 | Mar 2022 | Sep 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total Current Assets | 14913.8 | 14575.7 | 13565.5 | 14626.1 | 14199.7 |
Cash and Short Term Investments | 10917.2 | 11255 | 10547.9 | 11283.1 | 11636.8 |
Cash & Equivalents | 10917.2 | 11255 | 10547.9 | 11256.5 | 11636.8 |
Short Term Investments | 26.68 | 0 | |||
Total Receivables, Net | 578.787 | 533.094 | 515.985 | 505.028 | 313.615 |
Accounts Receivable - Trade, Net | 578.787 | 533.094 | 515.985 | 505.028 | 313.615 |
Total Inventory | 2102.31 | 1608.81 | 1550.15 | 1759.7 | 1468.61 |
Prepaid Expenses | 1165.26 | 1074.65 | 888.4 | 1074.74 | 769.716 |
Other Current Assets, Total | 150.262 | 104.12 | 63.125 | 3.541 | 11.017 |
Total Assets | 20747.6 | 20322.5 | 19202 | 19658.2 | 17739.2 |
Property/Plant/Equipment, Total - Net | 68.548 | 79.463 | 165.106 | 93.769 | 52.289 |
Goodwill, Net | 810.853 | 810.853 | 810.853 | 845.305 | 54.576 |
Intangibles, Net | 309.01 | 317.125 | 326.215 | 335.526 | 2.935 |
Long Term Investments | 4591.5 | 4499.12 | 4303.86 | 3747.42 | 3420.15 |
Note Receivable - Long Term | 20.024 | 24.215 | 13.03 | 10.07 | 9.524 |
Total Current Liabilities | 5437.44 | 5229.32 | 4822.13 | 5352.25 | 3400.87 |
Accounts Payable | 3714.05 | 3750.4 | 3528.6 | 4233.63 | 2551.55 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 37.437 | 36.045 | 50.656 | 25.423 | 20.334 |
Other Current Liabilities, Total | 1685.96 | 1442.88 | 1242.88 | 1093.2 | 828.988 |
Total Liabilities | 5573.85 | 5378.2 | 5103.55 | 5584.21 | 3437.25 |
Total Long Term Debt | 40.361 | 52.188 | 84.758 | 42.404 | 17.406 |
Capital Lease Obligations | 40.361 | 52.188 | 84.758 | 42.404 | 17.406 |
Deferred Income Tax | 122.417 | 116.107 | 116.483 | 114.226 | 39.322 |
Minority Interest | -26.374 | -25.838 | -26.187 | -25.564 | -20.346 |
Total Equity | 15173.7 | 14944.3 | 14098.4 | 14074 | 14302 |
Common Stock | 119.133 | 119.122 | 119.102 | 118.875 | 118.859 |
Additional Paid-In Capital | 43734.1 | 43674.9 | 43499.9 | 43399.4 | 43281.3 |
Retained Earnings (Accumulated Deficit) | -28706 | -29093 | -29261.2 | -29254.8 | -29031.4 |
Treasury Stock - Common | -70.482 | -11.549 | -23.516 | -32.596 | -22.265 |
ESOP Debt Guarantee | 477.237 | 416.542 | 460.077 | 419.61 | 363.949 |
Unrealized Gain (Loss) | 0.613 | 9.688 | 28.529 | 44.228 | 43.971 |
Other Equity, Total | -380.919 | -171.453 | -724.479 | -620.675 | -452.462 |
Total Liabilities & Shareholders’ Equity | 20747.6 | 20322.5 | 19202 | 19658.2 | 17739.2 |
Total Common Shares Outstanding | 13521.4 | 13520.1 | 13505.2 | 13477.3 | 13475.4 |
Other Liabilities, Total | 0 | 6.424 | 106.363 | 100.887 | |
Other Long Term Assets, Total | 33.831 | 16.013 | 17.39 |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Net income/Starting Line | -252.514 | 401.219 | 9.094 | -60.83 | |
Cash From Operating Activities | 255.69 | 424.363 | 1009.43 | 583.615 | 396.37 |
Cash From Operating Activities | 48.671 | 31.062 | 33.125 | 3.989 | |
Non-Cash Items | -247.119 | 178.196 | 265.003 | 168.324 | |
Cash Taxes Paid | 45.336 | 27.897 | 8.535 | 19.264 | |
Cash Interest Paid | 3.815 | 2.449 | 39.294 | 10.624 | |
Changes in Working Capital | 255.69 | 863.42 | 396.937 | 274.916 | 284.887 |
Cash From Investing Activities | -532.436 | 1872.31 | -4961.48 | 1345.39 | -2395.71 |
Capital Expenditures | -15.115 | -17.558 | -13.511 | -6.102 | |
Other Investing Cash Flow Items, Total | -532.436 | 1887.42 | -4943.93 | 1358.9 | -2389.61 |
Cash From Financing Activities | -111.278 | -58.628 | 8922.41 | 328.814 | 1708.49 |
Financing Cash Flow Items | -111.278 | -4.79 | -0.11 | -36.161 | -10.624 |
Issuance (Retirement) of Stock, Net | -6.826 | 8954.13 | 2094.75 | 19.113 | |
Issuance (Retirement) of Debt, Net | -47.012 | -31.616 | -1729.77 | 1700 | |
Foreign Exchange Effects | 283.447 | -148.891 | -313.057 | 56.796 | 62.804 |
Net Change in Cash | -104.577 | 2089.15 | 4657.29 | 2314.61 | -228.048 |
Amortization | 11.905 | 2.013 | 1.477 |
Mar 2023 | Sep 2022 | Mar 2022 | Sep 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 173.975 | -252.514 | -229.862 | 401.219 | |
Cash From Operating Activities | 255.69 | 504.049 | 424.363 | 597.704 | 1009.43 |
Cash From Operating Activities | 26.783 | 48.671 | 20.594 | 31.062 | |
Amortization | 9.114 | 11.905 | 2.465 | 2.013 | |
Non-Cash Items | 106.416 | -247.119 | -114.38 | 178.196 | |
Cash Taxes Paid | 18.507 | 45.336 | 40.699 | 27.897 | |
Cash Interest Paid | 3.362 | 3.815 | 0.737 | 2.449 | |
Changes in Working Capital | 255.69 | 187.761 | 863.42 | 918.887 | 396.937 |
Cash From Investing Activities | -532.436 | -736.551 | 1872.31 | 1341.08 | -4961.48 |
Capital Expenditures | -4.777 | -15.115 | -6.834 | -17.558 | |
Other Investing Cash Flow Items, Total | -532.436 | -731.774 | 1887.42 | 1347.91 | -4943.93 |
Cash From Financing Activities | -111.278 | -16.01 | -58.628 | -20.816 | 8922.41 |
Financing Cash Flow Items | -111.278 | 0 | -4.79 | -4.79 | -0.11 |
Issuance (Retirement) of Stock, Net | 8.185 | -6.826 | 6.2 | 8954.13 | |
Issuance (Retirement) of Debt, Net | -24.195 | -47.012 | -22.226 | -31.616 | |
Foreign Exchange Effects | 283.447 | 309.91 | -148.891 | -123.909 | -313.057 |
Net Change in Cash | -104.577 | 61.398 | 2089.15 | 1794.06 | 4657.29 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Alibaba Group Holding Ltd. | Corporation | 34.0604 | 4609501872 | 0 | 2023-08-30 | LOW |
Perfect Advance Holding Ltd. | Corporation | 22.9346 | 3103816661 | 0 | 2023-08-30 | LOW |
21CN Corporation | Corporation | 5.745 | 777484030 | 0 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.383 | 187164182 | 626000 | 2023-09-30 | LOW |
Krane Funds Advisors, LLC | Investment Advisor | 1.2999 | 175922000 | -156000 | 2023-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.8611 | 116533678 | 514000 | 2023-09-30 | LOW |
China Asset Management Co., Ltd. | Investment Advisor | 0.5353 | 72437638 | -2355488 | 2023-09-30 | LOW |
Bosera Asset Management Co., Ltd. | Investment Advisor | 0.5048 | 68318000 | 23196000 | 2023-06-30 | MED |
CSOP Asset Management Limited | Investment Advisor | 0.4801 | 64979382 | 111002 | 2023-09-30 | HIGH |
Fullgoal Fund Management Co., Ltd. | Investment Advisor/Hedge Fund | 0.453 | 61300000 | 34216000 | 2023-06-30 | MED |
State Street Global Advisors Asia Ltd. | Investment Advisor/Hedge Fund | 0.4488 | 60733868 | 1984348 | 2023-09-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.445 | 60227998 | -3438950 | 2022-12-31 | LOW |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.3589 | 48574033 | 370000 | 2023-09-30 | LOW |
E Fund Management Co. Ltd. | Investment Advisor | 0.3493 | 47266168 | 236000 | 2023-06-30 | LOW |
Bank of Communications Schroder Fund Management Co., Ltd. | Investment Advisor | 0.3005 | 40674000 | -4040000 | 2023-06-30 | MED |
UBS Asset Management (Hong Kong) Limited | Investment Advisor | 0.2785 | 37690000 | 0 | 2023-06-30 | LOW |
BlackRock (Singapore) Limited | Investment Advisor | 0.2677 | 36230877 | -1820253 | 2023-09-30 | HIGH |
Hang Seng Investment Management Ltd. | Investment Advisor | 0.206 | 27878099 | 2640 | 2023-09-30 | LOW |
Candriam Luxembourg S.A. | Investment Advisor | 0.2025 | 27399000 | 0 | 2023-09-30 | MED |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.1506 | 20377000 | -18000 | 2023-09-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Alibaba Health Company profile
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical e-commerce, intelligent medicine, and product tracking platform businesses in the People's Republic of China. The company engages in the B2C pharmacy business that provides outsourced and value-added services, and other related services to the Tmall entities, and centralized procurement and distribution businesses. It also operates Drug PIATS, a product identification, authentication, and tracking system for the drug industry; and a medical services network, as well as offers online health consultation services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. It has strategic collaboration agreement with Merck KGaA to develop patient-centric digital services. The company is based in Causeway Bay, Hong Kong. Alibaba Health Information Technology Limited is a subsidiary of Perfect Advance Holding Limited.Industry: | Internet & Mail Order Department Stores |
銅鑼灣勿地臣街1號時代廣場1座26樓
HK
Income Statement
- Annual
- Quarterly
News

December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com